These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27723829)

  • 1. Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
    Sagara A; Igarashi K; Otsuka M; Karasawa T; Gotoh N; Narita M; Kuzumaki N; Narita M; Kato Y
    PLoS One; 2016; 11(10):e0164250. PubMed ID: 27723829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
    Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
    Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMCA2 silencing potentiates MDA-MB-231 breast cancer cell death initiated with the Bcl-2 inhibitor ABT-263.
    Curry M; Roberts-Thomson SJ; Monteith GR
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1792-7. PubMed ID: 27613092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole].
    Hao J; Yuan BB; Xu YF; Yu J; Liu GY; Wang DH
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):419-24. PubMed ID: 22967442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
    J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
    Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocan as a prognostic biomarker of triple-negative breast cancer.
    Sagara A; Igarashi K; Otsuka M; Kodama A; Yamashita M; Sugiura R; Karasawa T; Arakawa K; Narita M; Kuzumaki N; Narita M; Kato Y
    Breast Cancer Res Treat; 2017 Jan; 161(2):269-278. PubMed ID: 27888420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2
    Yi J; Chen S; Yi P; Luo J; Fang M; Du Y; Zou L; Fan P
    Oncol Res; 2020 Dec; 28(5):519-531. PubMed ID: 32727638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil.
    Vinod BS; Antony J; Nair HH; Puliyappadamba VT; Saikia M; Narayanan SS; Bevin A; Anto RJ
    Cell Death Dis; 2013 Feb; 4(2):e505. PubMed ID: 23429291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of COX-2 in celecoxib-resistant breast cancer cell lines.
    Singh B; Irving LR; Tai K; Lucci A
    J Surg Res; 2010 Oct; 163(2):235-43. PubMed ID: 20691996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.
    Zhu H; Guo W; Zhang L; Davis JJ; Teraishi F; Wu S; Cao X; Daniel J; Smythe WR; Fang B
    Mol Cancer Ther; 2005 Mar; 4(3):451-6. PubMed ID: 15767554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.
    Lin X; Morgan-Lappe S; Huang X; Li L; Zakula DM; Vernetti LA; Fesik SW; Shen Y
    Oncogene; 2007 Jun; 26(27):3972-9. PubMed ID: 17173063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Celecoxib promotes apoptosis of breast cancer cell line MDA-MB-231 through down-regulation of the NF-kappaB pathway].
    Wang L; Liu LH; Shan BE; Zhang C; Sang MX; Li J
    Ai Zheng; 2009 Jun; 28(6):569-74. PubMed ID: 19635192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt/nuclear factor-κB signaling pathway.
    Lee KS; Lee DH; Chun SY; Nam KS
    Mol Med Rep; 2014 Aug; 10(2):1007-12. PubMed ID: 24859472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-beta-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: involvement of Akt, NF-kappaB and Bcl-2.
    Upadhyay AK; Singh S; Chhipa RR; Vijayakumar MV; Ajay AK; Bhat MK
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):177-85. PubMed ID: 16806341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax).
    Lam LT; Lu X; Zhang H; Lesniewski R; Rosenberg S; Semizarov D
    Mol Cancer Ther; 2010 Nov; 9(11):2943-50. PubMed ID: 20829195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.